Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain 14 Neoplasms 6 Colonic Neoplasms 5 Agnosia 5 Lung Neoplasms 4 Head and Neck Neoplasms 4 Cancer Pain 4 Breast Neoplasms 4 Rectal Neoplasms 3 Prostatic Neoplasms 3 Pain, Postoperative 3 Urinary Bladder Neoplasms 2 Sarcoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pleural Effusion, Malignant 2 Pancreatic Neoplasms 2 Lymphoma, Follicular 2 Diverticulosis, Colonic 2 Chronic Pain 2 Breakthrough Pain 2 post laminectomy syndrome 1 Waldenstrom Macroglobulinemia 1 Uterine Cervical Neoplasms 1 Thyroid Neoplasms 1 Thrombocythemia, Essential 1 Terminal Cancer 1 Sezary Syndrome 1 Primary Myelofibrosis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1

Interventions

Midazolam 1 Fentanyl 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Terminal Cancer × Fentanyl × Clear all

NCT02009306 2018-05-09

Nasal Fentanyl and Buccal Midazolam for Dying Patients

Gloucestershire Hospitals NHS Foundation Trust

Phase 4 Completed

Terminal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡